Accessibility
Legal Notices
Text Version

Irish Child Health Database - Peer Reviewed Papers

Database Search

How to use this database.

• Method 1- uses a free natural language approach.

  After choosing the object of the search – by ticking title, abstract, aims and objective, or author - enter a term, word or name in the ‘Search’ box to return references answering your research question.

• Method 2 - utilises key words.

  Those key words assigned from thesauruses of controlled vocabulary by the trained coders of international bibliographic databases.
  The controlled vocabularies key word are listed alphanumerically under 'Bibliographic database keywords' .
  Use the drop down menu to identity which 'key words' you are interested in to return references to answer your research question.

• Method 3 - is based on the indexing system

  developed by the researchers who compiled this database.
  It adopts a thematic approach to mapping Irish child health research. The themed areas represent outcomes mapped to the International Classification of Disease version 10 (ICD-10) or one of 23 other health-related themed outcomes. Themes are defined in Tables 5 to 7 (of the study report).
  Use the alphabetic drop down menu under ‘ICD-10 or themed health-related outcomes’ to identity which themed areas you are interested in to select references to answer your research question.

• Method 4 – allows papers to be searched by Study type.

  Indexing by study type offers a valuable insight into understanding the population impact of the topic of interest. More than 20 study types were identified across the 2,152 study papers. These are defined in Table 3 (of the study report). Within 'Study type' papers are further stratification by geographical region (Table 49), topic area of interest and study aims and objectives.
  Click on 'Study type' to select the type of study of interest, progressively select sub-categories by topic area or other sub-classification of interest to answer your research question.

The complete background, methods and findings from this mapping exercise are detailed in the study report.

Dexamethasone/adverse effects/ therapeutic use

Your search returns 3 documents

• 1.   Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants

  The aim of this review was to determine if postnatal corticosteroid treatment is of benefit in the prevention of chronic lung disease in the preterm infant

  

  Abstract:

  BACKGROUND: Chronic lung disease (CLD) remains a major problem in neonatal intensive care units. Persistent inflammation in the lungs is the most likely underlying pathogenesis. Corticosteroids have been used to either prevent or treat CLD because of their potent anti-inflammatory effects. OBJECTIVES: To determine if postnatal corticosteroid treatment is of benefit in the prevention of more...

  International Classification:

  Systematic Review

  Categories:

  corticosteroid treatment chronic lung disease preterm infant

  Geography:

  Systematic Review

  Cochrane Database Syst Rev, 2001
  H. L. Halliday; R. A. Ehrenkranz

  [Preview] [Read]

• 2.   Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes

  The aim of this study was to assess neurologic, educational, and psychological status in adolescence of neonates enrolled in a double-blind, randomized, controlled trial of dexamethasone therapy for chronic lung disease

  

  Abstract:

  OBJECTIVES: To study neurologic, educational, and psychological status in adolescence of neonates enrolled in a double-blind, randomized, controlled trial of dexamethasone therapy for chronic lung disease. PARTICIPANTS: A total of 287 infants who were chronically dependent on supplementary oxygen and were 2 to 12 weeks of age were recruited from 31 centers in 6 countries to a more...

  International Classification:

  Evaluation of the effectiveness of treatments - chronic lung disease on later life neurological outcomes

  Categories:

  outcomes on trial of dexamethasone therapy for chronic lung disease

  Geography:

  Republic of Ireland and the United Kingdom

  Pediatrics, Vol: 116 Page: 370-8 August 2005
  R. A. Jones

  [Preview] [Read]

• 3.   Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure

  The aim of this study was to assess the growth, health status, and respiratory outcomes at 13 to 17 years of infants enrolled in a double-blind, randomized, controlled trial of dexamethasone for the treatment of neonatal chronic lung disease

  

  Abstract:

  OBJECTIVES: To study the growth, health status, and respiratory outcomes at 13 to 17 years of infants enrolled in a double-blind, randomized, controlled trial of dexamethasone for the treatment of neonatal chronic lung disease. PARTICIPANTS: A total of 287 infants who were chronically dependent on supplementary oxygen between 2 and 12 weeks of age were recruited from 31 centers in 6 more...

  International Classification:

  Evaluation of the effectiveness of treatments - neonatal chronic lung

  Categories:

  treatment of neonatal chronic lung disease

  Geography:

  Republic of Ireland and the United Kingdom

  Pediatrics, Vol: 116 Page: 379-84 August 2005
  R. A. Jones

  [Preview] [Read]